These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 1685312

  • 41. Distinct sites of dopaminergic and glutamatergic regulation of haloperidol-induced catalepsy within the rat caudate-putamen.
    Yoshida Y, Ono T, Kawano K, Miyagishi T.
    Brain Res; 1994 Mar 07; 639(1):139-48. PubMed ID: 7910107
    [Abstract] [Full Text] [Related]

  • 42. Levorphanol but not dextrorphan suppresses the foot-lifting response to an aversive thermal stimulus in the terrestrial snail, Cepaea nemoralis.
    Hirst M, Kavaliers M.
    Neuropharmacology; 1987 Mar 07; 26(2-3):121-3. PubMed ID: 3587526
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Biphasic action of dextrorphan on penicillin induced bursting in rat hippocampal slice.
    Aryanpur J, Cole AE, Eccles CU, Fisher RS.
    Brain Res; 1990 Jun 11; 519(1-2):65-72. PubMed ID: 1975767
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Cyclosomatostatin- and haloperidol-induced catalepsy in Wistar rats: Differential responsiveness to sleep deprivation.
    Ionov ID, Pushinskaya II, Gorev NP, Frenkel DD.
    Neurosci Lett; 2018 Sep 25; 684():72-77. PubMed ID: 29990558
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Differential tolerance to cataleptic effects of SCH 23390 and haloperidol after repeated administration.
    Lappalainen J, Hietala J, Syvälahti E.
    Psychopharmacology (Berl); 1989 Sep 25; 98(4):472-5. PubMed ID: 2570432
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Effects of age and isolation on the evolution of catalepsy during chronic haloperidol treatment.
    Frussa-Filho R, Otoboni JR, Uema FT, Palermo-Neto J.
    Braz J Med Biol Res; 1992 Sep 25; 25(9):925-8. PubMed ID: 1342840
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Sensitization versus tolerance to haloperidol-induced catalepsy: multiple determinants.
    Barnes DE, Robinson B, Csernansky JG, Bellows EP.
    Pharmacol Biochem Behav; 1990 Aug 25; 36(4):883-7. PubMed ID: 2217518
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.